The Impact of Artificial Intelligence on Value-Based Care in Orthopaedics

By Michael Awood

October 6, 2023

In healthcare, artificial intelligence has made considerable strides. It has the potential to enhance prediction, diagnosis, and decision-making. Researchers in orthopaedic surgery, where AI technologies have the potential to alter the discipline, have also seen this.

They can apply artificial intelligence in orthopaedics to find trends in data. Predicting patient risk potential or bad occurrences, for example, offers clinicians with crucial information. Despite the label “experimental,” there is mounting evidence that AI is successful and suitable for widespread use.

AI can help physicians and patients collaborate in the next steps. This points to a more cooperative intelligence. Physicians can give patient-specific risk-benefit ratios by feeding patient-reported outcomes into machine-learning algorithms. Doctors can use machine-learning algorithms to expect the results or advantages of arthroplasty surgery. However, we need further research to determine how these choice aids improve outcomes and provide value.

AI use in healthcare is fraught with ethical, legal, regulatory, and practise considerations. How should we get patients’ consent for AI-enabled robotic-assisted procedures? Surgeons must work with programmers to verify that the algorithm outputs match the demands of the patients.

It also poses questions regarding the current medical education programme, ultimately suggesting a redesign. Future professionals must learn to interact with and adapt to this technology for safe use in clinical settings.

However, there is a significant value proposition for AI in healthcare, particularly in terms of cost. AI technologies have the potential to reduce expenses by saving time and resources. These also impact patients’ experiences and outcomes. Getting clinician buy-in for the cultural shift, as well as assessing the initial cost, are essential concerns to balance against these potential savings.

AI has enormous potential in orthopaedics. To explore how artificial intelligence may aid orthopaedic patients, we need to test and assess it in clinics, prioritising its worth. According to the article, value is determined by weighing the advantages of new instruments against their entire expenses.

 

Cover image: stefamerpik on freepik

Reference url

Recent Posts

NICE Endorses Rozanolixizumab for Myasthenia Gravis Treatment

By João L. Carapinha

May 1, 2026

Rozanolixizumab myasthenia gravis treatment has been recommended by the National Institute for Health and Care Excellence (NICE) as an add-on to standard care for adults with generalised myasthenia gravis (gMG) who are positive for anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosi...
Accelerating Biotechnology Patient Access in Europe Through Strategic Policy Reforms
The biotechnology patient access gap in Europe remains a critical challenge despite the continent’s scientific excellence. The EU Biotech Act offers a strategic opportunity to accelerate the delivery of advanced therapies — such as radioligand, cell and gene, and RNA-based treatments — from disco...
Insulin Substitution Portugal: Implications of Novo Nordisk’s Discontinuation
INFARMED has informed healthcare professionals about the upcoming discontinuation of several Novo Nordisk insulin products in Portugal and to provide clear guidance on insulin substitution Portugal. On 30 April 2026, INFARMED issued Circular 045/CD/100.20.200 announcing that Novo Nordisk Portu...